- Global Pharma News & Resources

Impact of Covid19 on Atherectomy Market, Future Growth 2020-2027 | Phillips Healthcare, Bayer AG, BARD Peripheral Vascular Inc, Boston Scientific, etc

: New York, United States, 05-August-2020, (Via WiredRelease), (Reports and Data) – According to the current analysis of Reports and Data, The global Atherectomy market was valued at USD 1.12 Billion in 2018 and is expected to reach USD 1.88 Billion by year 2026, at a CAGR of 6.6%. Atherectomy is a procedure to remove plaque from an artery. Removing plaque makes the artery wider so the blood can flow more freely to the muscles. This procedure is used to treat peripheral artery disease and coronary artery disease. The procedure is sometimes performed on patients with very hard plaque or on patients who have already had an angioplasty and stents but still have plaque blocking the blood flow. The procedure is specifically designed to treat narrowing in arteries caused by peripheral artery diseases. It is a frequently opted alternative to Angioplasty. The surgery is not too costly either making it an apt alternative to angioplasty. The surgery is quicker than the traditional open surgery and thus is preferred by most. In addition, it is a faster and a simpler procedure to perform and therefore is advised by many surgeons.

Get Sample Copy with TOC of the Report to understand the structure of the complete report @

The COVID-19 impact:
Covid-19’s spread has affected manufacturing and construction activities worldwide. Logistic limitations and reconsiderations of the raw material requirements are becoming a problem for producers. The producers have relied on derived demand as an intermediate commodity to rationalize production. The pandemic’s economic impact on companies and financial markets is also not favorable. Stock market volatility and decreasing global growth are anticipated, which will affect the market.  The market has experienced a downturn over the weeks, which may continue over the next few months. The Asia Pacific is the most affected region by this pandemic, with China at the center of the outbreak. Most initiatives in multiple countries have changed to a temporary halt. Development, as well as supply, is put on hold, creating losses for suppliers, dealers and customers alike.

Key participants include

Phillips Healthcare, Bayer AG, BARD Peripheral Vascular Inc., Boston Scientific, Medtronics, Cardiovascular Systems Inc. and Avinger Inc.

Get Discount on the report @

For the purpose of this report, Reports and Data have segmented into the global Atherectomy market on the basis of type, propellants, application, and region:

Type (Revenue, USD Million; 2016–2026)


Application (Revenue, USD Million; 2016–2026)

Peripheral Artery DiseasesCoronary Artery DiseaseNeurovascular Disease

End Use (Revenue, USD Million; 2016–2026)

HospitalsAmbulatory Care CentersMedical Research InstitutesCardiac Catherization LabOther

Regional Outlook (Revenue, USD Million; 2017-2027)

North America





Asia Pacific





Latin America


To identify the key trends in the industry, click on the link below:

Key Question the Report Will Answers

At what rate will the Atherectomy Market grow? What will be the value of the market in 2027?

What are the key technologies driving Atherectomy?

What would be the impact of Atherectomyacross different regions?

What are the strategies adopted by players to enter the APAC region?

What is the key application of Atherectomyin the transportation sectors?

What are future growth strategies in the market?

About Us:
Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development.

Contact Us:
John Watson
Head of Business Development
Reports and Data | Web:
Direct Line: +1-212-710-1370

This content has been published by MARKETYSERS GLOBAL CONSULTING LLP company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 05-Aug-2020